NCT07179783
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +14 more
- Locations
-
- Tianjin Medical Unversity Second Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Prostate Adenocarcinoma With Neuroendocrine Differentiation
Explore clinical trials studying Prostate Adenocarcinoma With Neuroendocrine Differentiation. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Prostate Adenocarcinoma With Neuroendocrine Differentiation trial results
Active, Not Recruiting
Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer
NCT02893917
- Conditions
- Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation, Castration-Resistant Prostate Carcinoma, Genital Diseases, +13 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States